
Tiziana Life Sciences Ltd
TLSAHealthcare|Biotechnology|GB
$0.69
+0.07 (+11.03%)
DCF Value
$0.01
Cash / Share
$0.02
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Jan 22, 2026 (424B5). Possible dilution.
Upcoming Data Readouts (1)
Apr 2027
Est. completion
P2Multiple System Atrophy
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
NCT06868628n=5
Awaiting Results (1)
Trials past primary completion date but still active — data readout may be imminent.
Sep 2026
P2
A Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients
NCT06292923Recent Press Releases
Tiziana to Host Investor Call with Key Opinion Leaders to Discuss Positive Phase 2a INFORM-MS Topline Results
Nov 5, 2026 · GlobeNewsWire
Tiziana Management Team to Attend the 10th Joint ACTRIMS-ECTRIMS Meeting in Toronto
Oct 21, 2026 · GlobeNewsWire
Tiziana Doses Last Patient in Phase 2 Trial of Intranasal Foralumab for Mild Alzheimer's Disease
Oct 16, 2026 · GlobeNewsWire
SEC Filings (95)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Nov 5, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Nov 2, 2026 | 6-K/A | Foreign issuer report | DocumentIndex |
| Nov 2, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 21, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 16, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Oct 16, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 30, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 28, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 21, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Sep 17, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 24, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 6, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Aug 4, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 31, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jul 22, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 25, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jun 15, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 28, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 21, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 19, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 14, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| May 1, 2026 | 20-F | Annual report (foreign) | DocumentIndex |
| Apr 30, 2026 | NT 20-F | DocumentIndex | |
| Apr 16, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 14, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Apr 1, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 25, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Feb 20, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jan 22, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jan 22, 2026 | AW | DocumentIndex | |
| Jan 21, 2026 | POS AM | DocumentIndex | |
| Jan 20, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 16, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 16, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Jan 16, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Jan 9, 2026 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 29, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 19, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 17, 2025 | 6-K | Foreign issuer report | DocumentIndex |
| Dec 17, 2025 | 6-K | Foreign issuer report | DocumentIndex |